MedPath

Effects of Moderate Consumption of Lean Fish on Weight Loss

Not Applicable
Completed
Conditions
Obesity
Overweight
Interventions
Behavioral: Fish group
Behavioral: Control group
Registration Number
NCT03120429
Lead Sponsor
Novindiet Clinic
Brief Summary

the aim of present study is to compare the specific effects moderate consumption of lean fish on weight loss of healthy obese and overweight female adults, while participants follow energy-restricted diets also to investigate the effects of this intervention on carbohydrate and lipid profiles, as cardiometabolic risk factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • female
  • 18-45 years of age.
  • Body mass index (BMI) between 27.5-35 kg/m²
  • Must be able to have moderate exercise.
  • Must be interested to lose weight
Exclusion Criteria
  • Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months.
  • Taking medications that could affect metabolism or change body weight.
  • Report heart problems, chest pain, and cancer within the last five years.
  • Use of supplements containing n-3 fatty acids, calcium or vitamin-D during the last 3 months.
  • Consumption of fish and sea foods regularly
  • Smoking
  • Menopause
  • Diagnosis of any chronic disease such as fatty liver, cancer, chemo/radio therapy, heart disease, immune compromised conditions, abnormal thyroid hormone level.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fish groupFish groupsubjects will have 3 x 150 g lean fish/ week at main meal
Control groupControl groupsubjects will have no seafood.
Primary Outcome Measures
NameTimeMethod
weight loss24 Weeks

kg

Secondary Outcome Measures
NameTimeMethod
waist circumference24 Weeks

cm

lipid profiles24 Weeks

mmol/l

serum insulin level24 Weeks

mU/l

insulin resistance (HOMA-IR)24 Weeks

score

glycosylated hemoglobin (HbA1c)24 Weeks

percentage (%)

fasting plasma glucose24 Weeks

mmol/l

liver enzymes (SGOT, SGPT)24 Weeks

U/l

Trial Locations

Locations (1)

NovinDiet Clinic

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath